Ghent University Academic Bibliography

Your filters: cql: author="Vandermeulen, Corinne" or (type any "bookEditor issueEditor" and editor="Vandermeulen, Co...

Add to list
- Journal Article
- A1
- open access
Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults : phase 1/2 randomized clinical trial

Isabel Leroux-Roels (UGent) , Matthew G Davis, Katie Steenackers, Brandon Essink, Corinne Vandermeulen, Charles Fogarty, Charles P Andrews, Edward Kerwin, Marie Pierre David, Laurence Fissette, et al.

(2023) JOURNAL OF INFECTIOUS DISEASES. 227(6). p.761-772
Add to list
- Journal Article
- A2
- open access
Long-term immunogenicity and safety of a non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine : 4-year follow-up of a phase 1 multicentre trial

Philippe De Smedt, Geert Leroux-Roels (UGent) , Corinne Vandermeulen (UGent) , Annaelisa Tasciotti, Gennaro Di Maro, Marie Dozot, Daniela Casula, Margherita Annaratone, Daniele Riccucci and Ashwani Kumar Arora

(2021) VACCINE: X. 9.
Add to list
- Journal Article
- A1
- open access
Influenza vaccination in patients with congenital heart disease in the pre-COVID-19 era : coverage rate, patient characteristics, and outcomes

Philip Moons, Steffen Fieuws, Corinne Vandermeulen, Fouke Ombelet, Ruben Willems (UGent) , Eva Goossens, Liesbet Van Bulck, Michèle de Hosson (UGent) , Lieven Annemans (UGent) , Werner Budts, et al.

(2021) CANADIAN JOURNAL OF CARDIOLOGY. 37(9). p.1472-1479
Add to list
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age : an open-label phase 3 study

Elmar A. Joura, Angels Ulied, Corinne Vandermeulen, Milagrosa Rua Figueroa, Ilkka Seppa, Juan Jose Hernandez Aguado, Anitta Ahonen, Olaf Reich, Miia Virta, Antonino Perino, et al.

(2021) VACCINE. 39(20). p.2800-2809
Add to list
- Journal Article
- A1
- open access
Antibody persistence and booster responses to split-virion H5N1 avian influenza vaccine in young and elderly adults

Rajeka Lazarus, Sarah Kelly, Matthew D Snape, Corinne Vandermeulen, Merryn Voysey, Karel Hoppenbrouwers, Annick Hens, Pierre Van Damme, Stephanie Pepin, Isabel Leroux-Roels (UGent) , et al.

(2016) PLOS ONE. 11(11).
Add to list
Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice

Corinne Vandermeulen, Lieven Verhoye (UGent) , Sunil Vaidya, Frédéric Clement (UGent) , Kevin E Brown, Karel Hoppenbrouwers and Geert Leroux-Roels (UGent)

(2010) IMMUNOLOGY. 131(1). p.33-39
Add to list
Evaluation of cellular immunity to mumps in vaccinated individuals with or without circulating antibodies up to 16 years after their last vaccination

Corinne Vandermeulen, Frédéric Clement (UGent) , Mathieu Roelants, Pierre Van Damme, Karel Hoppenbrouwers and Geert Leroux-Roels (UGent)

(2009) JOURNAL OF INFECTIOUS DISEASES. 199(10). p.1457-1460
Add to list
Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults

Isabel Leroux-Roels (UGent) , Marie Van der Wielen, Froukje Kafeja, Corinne Vandermeulen, Rajeka Lazarus, Matthew D Snape, Tessa John, Christophe Carre, Nolwenn Nougarede, Stephanie Pepin, et al.

(2009) VACCINE. 27(49). p.6918-6925
Add to list
An adjuvanted, low-dose, pandemic influenza a (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults

Karin Levie, Isabel Leroux-Roels (UGent) , Karel Hoppenbrouwers, Anne-Diane Kervyn, Corinne Vandermeulen, Sheron Forgus (UGent) , Geert Leroux-Roels (UGent) , Sylvie Pichon and Inca Kusters

(2008) JOURNAL OF INFECTIOUS DISEASES. 198(5). p.642-649

Academic Bibliography

Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults : phase 1/2 randomized clinical trial

Long-term immunogenicity and safety of a non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine : 4-year follow-up of a phase 1 multicentre trial

Influenza vaccination in patients with congenital heart disease in the pre-COVID-19 era : coverage rate, patient characteristics, and outcomes

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age : an open-label phase 3 study

Antibody persistence and booster responses to split-virion H5N1 avian influenza vaccine in young and elderly adults

Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice

Evaluation of cellular immunity to mumps in vaccinated individuals with or without circulating antibodies up to 16 years after their last vaccination

Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults

An adjuvanted, low-dose, pandemic influenza a (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults

Contents

Support

Contact